FH-FOLR1 ST CAR T Cells

folate receptor alpha-targeted CAR T cells · Fred Hutchinson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FH-FOLR1 ST CAR T Cells, covering 2026-02-11 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial [Phase 1]

See pricing